期刊文献+

尿微量白蛋白检测在高血压病及糖尿病肾病诊断中的应用 被引量:8

Application of Detection of Albumin in the Diagnosis of Hypertensive and Diabetic Nephropathy Disease
下载PDF
导出
摘要 目的探讨尿微量白蛋白测定在高血压病及糖尿病肾病中的应用价值。方法将研究对象分为高血压病组(63例)、糖尿病组(40例)、糖尿病肾病组(42例)、高血压合并糖尿病组(48例)及健康对照组(45例),检测其晨尿中微量白蛋白的含量和血中尿素氮、肌肝的含量。结果①高血压病组、糖尿病组、糖尿病肾病组及高血压合并糖尿病组中尿微量白蛋白与对照组比较,差异均有显著性(P<0.01)。②糖尿病组、高血压组及高血压合并糖尿病组中尿微量白蛋白依次增高。结论①肾功能损害与血压水平有关。②高血压比血糖更容易加重患者肾脏损害。③高血压病及糖尿病患者应进行尿微量白蛋白含量的筛查,这有利于糖尿病患者肾病及其心血管并发症的早期预防和干预治疗。 Objective To observe the clinical value of detection of urine minimum albumin in diagnosis of hypertensive and diabetic nephropathy disease.Methods All the case were divided into five groups:hypertensive disease group(n=63),diabetic group(n=40),diabetic nephropathy group(n=42),hypertensive disease complicating high blood gulcose group(n=48) and healthy controls(n=45).Determination of the urine minimumalbumin,urea nitrogen of blood and creatininein of blood in all the case was made.Results ①The concentration of urine minimumalbumin of hypertensive disease group,diabetic group,diabetic nephropathy group and hypertensive disease complicating high blood gulcose group was significant difference as compared with that of healthy controls(P0.01).②The concentration of urine minimumalbumin increased in diabetic group、hypertensive disease and hypertensive disease complicating high blood gulcose group.Conclusion①The impairment of renal function is relevant with the level of blood pressure.②Compared with high blood glucose,high pressure aggravate the impairment of renal function easily.③The determination of concentration of urine minimum albumin in diabetic patient is useful for early diagnosis and intervention of hypertensive group and diabetic disease group.
出处 《实用临床医学(江西)》 CAS 2010年第1期13-15,共3页 Practical Clinical Medicine
关键词 尿微量白蛋白 高血压病 糖尿病 糖尿病肾病 诊断 urine minimum albumin hypertensive disease diabetes mellitus diabetic nephropathy diagnosis
  • 相关文献

参考文献9

  • 1Weir M R.Microalbuminuria and cardiovascular disease[J].Clin J Am Soc Nephrol,2007,2(3):581-590.
  • 2Bohm M,Thoenes M,Danchin N,et al.Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals:the i-SEARCH Global Study[J].J Hypertens,2007,25(11):2317-2324.
  • 3陈青云,杨艳,覃伟武,彭育欢,罗秋萍,黎水莲,廖蕴华,赖璐华,陈莹.代谢综合征组分与尿微量白蛋白发生率的关系[J].中华高血压杂志,2007,15(4):289-293. 被引量:20
  • 4Czekalski S.Diabetic nepbropathy and cardiovascular disease[J].Rocz Akad Med Bialymst,2005,50(2):122-125.
  • 5王鲁雁,孙宁玲,常玲,刘喜荣.高血压糖尿病患者尿微量白蛋白与动脉弹性之间的关系[J].中华心血管病杂志,2006,34(5):387-390. 被引量:36
  • 6Kikumoto Y,Wada J,Makino H.The application of synthetic hANP in diabetic nephropathy with nephrotic syndrome[J].Diabetes Care,2006,29(1):172-173.
  • 7Narita T,Hosoba M,Kakei M,et al.Increased urinary excretions of immunoglobulin gceruloplasmin,and transferrin predict development of microalbuminuria in patients with type 2 diabetes[J].Diabetes Care,2006,29(1):142-144.
  • 8Matteucci E,Rosada J,Pinelli M,et al.Systolic blood pressure response to exercise in type 1 diabetes families compared with healthy control individuals[J].J Hypertens,2006,24 (9):1745-1751.
  • 9Thomas M C,Atkins R C.Blood pressure lowering for the prevention and treatment of diabetic kidney disease[J].Drugs,2006,66(17):2213-2234.

二级参考文献21

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2619
  • 2[1]Philipou G,Philips PJ.Variability of urinary albumin excretion in patients with microalbuminuria[J].Diabetes Care,1994,17:425-427.
  • 3[2]International Diabetes Federation:The IDF consensus worldwide definition of the metabolic syndrome.Available at:www.idf.org/ webdata/docs/ Metabolic-syndrome-definition.pdf.Accessed April 18,2005.
  • 4[4]American Diabetes Association.Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus (Consensus Statement)[J].Diabetes Care,1994,17:1357.
  • 5[5]Kim YI,Kim CH,Choi CS,et al.Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population[J].Diabetes Research and Clinical Practice,2001,52:145-152.
  • 6[6]Ulla Derhaschnig,Harald K,Christian W,et al.Microalbumin measurement alone or calculation of the albumin/creatinine ratio for the screening of hypertension patients[J].Nephrol Dial Transplant,2002,17:81-85.
  • 7[8]Eric L,Knight and Gary C,Curhan.Albuminuria:moving beyond traditional microalbuminuria cut-points[J].Current Opinion in Nephrology and Hypertension,2003,12:283-284.
  • 8[10]Ribstein J,Du Cailar G,Mimran A.Combined renal effects of overweight and hypertension[J].Hypertension,1995,26:610-615.
  • 9[11]Meigs JB,Jacques PF,Selhub J,et al.Fasting plasma homocysteine levels in the insulin resistance syndrome:the Fragmingham offspring study[J].Diabetes Care,2001,24:1403-1410.
  • 10Kim KS,Koh JM,Song KH,et al.Incidence of overt proteinuria and coronary artery disease in patients with type 2 diabetes mellitus:the role of microalbuminuria and retinopathy.Diabetes Res Clin Pract,2004,65:159-165.

共引文献49

同被引文献59

  • 1张维忠,龚兰生.动态血压与高血压性左室肥厚的关系[J].中华心血管病杂志,1993,21(3):138-140. 被引量:138
  • 2郭舜奇,唐小玲,许少英.高血压患者脉压对尿微量白蛋白的影响[J].中华高血压杂志,2006,14(10):839-840. 被引量:15
  • 3Chobanian AV, Bakris GL, Black HR, et al . The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA,2003 ,289(19) :2560 - 2572.
  • 4Veerman DP, De Blok K, Van Monffrans A. Relationship of steady state and ambulatory blood pressure variability to left ventricular mass and urinary albumin excretion in essential hypertensi on. J Hypertens,1996,9(5) :455 -460.
  • 5Leoncini G, Ratto E, Viazzi F, et al. The role of microal buminuria in the overall risk assessment of hypertensive patients. G Ital Nefrol, 2007,24 ( 6 ) :565 - 573.
  • 6刘力生,龚兰生,孔灵芝.中国髙血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005 :13-8.
  • 7Yang CW, Park JT, Kim YS, et al. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hyper- tension:dam from Korean Epidemiology Study on Hypertension Ⅲ ( KEY HI study) [ J]. Nephrology Diaysis Transplanation,2011,26 (10) :3249.
  • 8Czekalski S. Diabetic nephropathy and cardiovascular dis- eases[J]. RoezAkad MedBialymst ,2005,50(2) :122.
  • 9Katharina-Susanne S,Barbara K,Eberhard R. Serum Creati-nine,Cystatin C,and –Trace Protein in Diagnostic Staging and Pre-dicting Progression of Primary Nondiabetic Chronic Kidney Disease[J].Clinical Chemistry,2010,(05):1.
  • 10Miller WG,Bruns DE,Hortin GL. Current issues inmeasurement and reporting of urinary albumin excretion[J].Clinical Chemistry,2009,(01):24238.

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部